27.04.2020 Novavax Inc Daily Analysis

27.04.2020 Novavax Inc Daily Analysis

Novavax Inc (NVAX) 19.83usd ,-0.55, -2.70% The coronavirus vaccines are being developed at a rapid speed as more than 2.9 million people have been infected with the virus across the globe, and 190,858 have died so far and Novavax keeps on facing a lot of pressure from different competitors and that is why today it is trading on 19.83usd  and it went down with almost 2.70 percent. This down tıurn was seen after The World Health Organization announced that there are six coronavirus vaccines that are currently seeing clinical trials. This includes Oxford University, Moderna Inc, Inovio Pharmaceuticals Inc, China's Sinovac, CanSino Biological Inc., and Beijing Institute of Biological Products and also that they are 77 coronavirus vaccines that are in pre-clinical stages including Novavax. This announcement gave traders a lot of options to look up to as they are now more pharmaceuticals that are working on the cure.